Synsight
The AI engine Fit Assessment
BetaSynsight leverages machine learning and deep learning to discover new patterns and expand therapeutic options, optimizing the drug discovery process.
Blurb
Synsight specializes in molecular modeling, bioinformatic, and structural biology fields.
HQ Location
Évry-Courcouronnes (France)
Founded
2013
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Acquired by Iktos, July 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
Developer of a drug discovery platform designed to combine artificial intelligence, molecular modeling and functional content screening. The company's platform specializes in molecular modeling, bioinformatics and structural biology to secure and efficient new molecules, enabling clients to improve and accelerate their research.